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The Helicobacterpylorifatty acid cism9,10
methyleneoctadecanoic acid stimulates protein kinase
C and increases DNA synthesis of gastric HM02 cells
W Beill, B Obst', S Wagner2 and KF Sewing'
Departments of 'General Pharmacology and 2Gastroenterology and Hepatology, Hannover Medical School, D-30625 Hannover, Germany
Summary Protein kinase C (PKC) has been implicated in the control of epithelial proliferative activity and in the process of malignant
transformation. Helicobacter pylori (H.p.) infection is associated with increased gastric epithelial cell proliferation and has been linked with
gastric carcinoma. In the present study, we report that the H.p. fatty acid cis-9,10-methyleneoctadecanoic acid (MOA) directly activates PKC
(Ka 3.3gM). The effect of MOA upon PKC activation was Ca2+ dependent but did not require phosphatidylserine as phospholipid cofactor.
MOA increased the stimulatory effect of phosphatidylserine at low Ca2+ (1 gM) concentrations. These findings indicate that MOA interacts at
the phospholipid- and the diacylglycerol-binding domain to elicit PKC activation. Treatment of gastric mucous cells HM02 caused
translocation of PKC from the cytosol to the nuclear, mitochondrial and membrane fraction. Furthermore, MOA stimulated [3H]thymidine
incorporation into the DNA of HM02 cells. Our results showthat the H.p. fatty acid MOA activates PKC and increases DNA synthesis in gastric
epithelial cells.
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Protein kinase C (PKC) is a family ofenzymes that plays a pivotal
role in transmembrane signalling, cell growth and cell division
(Nishizuka, 1986; Clemens et al, 1992). Diacylglycerol (DAG), a
breakdown product of polyphosphoinositides, is a physiological
effector ofthis(ese) enzyme(s). Tumour-promoting phorbol esters,
such as 12-O-tetradecanoyl-phorbol-13-acetate (TPA), which
interact with the DAG site, are activators oftheenzyme and several
lines ofevidence indicate that tumour promotion is related to PKC
activation (Martelly and Castagna, 1989). Other tumour promoters
structurally unrelated to TPA have alsobeen described as activators
of PKC, such as teleocidin B (Fujiki et al, 1984), chloroform
(Roghani et al, 1987) and bile acids (Huang et al, 1992).
Helicobacter pylori (H.p.) is a Gram-negative bacterium that
causes chronic gastritis and peptic ulcer diseases (NIH Consensus
Conference, 1994). Moreover, an association between the micro-
organism and gastric cancer has been demonstrated by epidemio-
logical studies (Forman, 1993), but a causal link between gastric
cancer and H.p. infection has not been proven. H.p. produces
unusual fatty acids such as cis-9,10-methyleneoctadecanoic acid
(Goodwin et al, 1985). Cis-unsaturated fatty acids are known as
tumour promoters (Bull et al, 1981) and PKC activators (McPhail
et al, 1984).
There is some evidence that PKC plays a crucial role in gastric
epithelial proliferation. Epidermal growth factor (EGF) and trans-
forming growth factor a (TGF-a) have been reported to be mito-
genic for primary cultured gastric parietel, chief and mucous cells
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(Chen et al, 1991; Rutten et al, 1993). In addition to the ability of
these growth factors to stimulate tyrosine kinase activity, to
increase inositol trisphosphate and to interact with G proteins,
EGF has been shown to activate PKC (Reynolds et al, 1993; Wang
et al, 1996). Overexpression of EGF, TGF-a and their receptor
genes are thought to participate in the rapid cell proliferation seen
in gastric cancer (Pfeiffer et al, 1990).
Based on these observations, we have examined the character-
istics of cis-9,10-methyleneoctadecanoic acid (MOA)-mediated
PKC activation and the effect ofMOA on cellular DNA synthesis.
MATERIALS AND METHODS
Materials
Rat brain PKC (a mixture of alpha-, beta- and gamma-isoforms)
purified to greater than 97% by the method of Allen and Katz
(1991) was purchased from Biomol (Hamburg, Germany). MOA
(purity 99%) was synthesized by J Holzkampf (Department of
Organic Chemistry, University of Hanover, Hanover, Germany).
Glycogen synthase peptide was obtained from Bachem
(Heidelberg, Germany). Fetal calf serum was obtained from Life
Technologies (Eggenstein, Germany). [y-32P]ATP and [3H]thymi-
dine was obtained from Hartmann Analytic (Braunschweig,
Germany). All other chemicals and media were purchased from
Sigma (Munich, Germany).
Determination of protein kinase C activity
PKC was determined in areaction mixture (50 gl) containing 20mM
Hepes (pH 7.4), 0.2 mM EGTA, 10 mm magnesium chloride, 40,M
Part ofthis work was presented at the 97th meeting ofthe American
Gastroenterological Association in San Francisco, on May 19, 1996 and was
published in abstract forn (Gastroenterology 110: A 63, 1996).
1852H. pyloriMOA stimulates PKC 1853
2000 r
.a)
2
a
1000 _
E
0c
E
C
0L
*
* /
*/
y ' ______
0 5
Methyleneoctadecanoic acid (gM)
6000
7
E
C
.a)
2
0, 3000
E
E-
E
c
A
0L ETr 6 1-
EGTA 6
10
Figure 1 Protein kinase C activation by MOA in absence (0) and presence
(0) of 200gM free Ca2+. Results are means ± s.e.m. of three independent
experiments. *P < 0.05 vs Mg2+-dependent (0) phosphorylation
[32P]ATP (500 c.p.m. pmol-1), 100gM glycogen synthase peptide,
leupeptin 1 jig and 5 ng of brain enzyme. Calcium chloride, TPA
(dissolved in dimethyl sulphoxide), sonicated suspensions of MOA,
phosphatidylserine and 1,2-dioctanoyl-sn-glycerol (DIC8) were
added separately, as described in the text. Incubation proceeded for
S min at 300C and was terminated with 20 jil of an acetic acid-
trichloroacetic acid solution. An aliquot (35 Rl) of the solution was
spotted onto Whatman P-81 phosphocellulose paper, washed three
times in acetic-phosphoric acid (30%/1%) and counted by liquid
scintillation analysis.
The determination of PKC translocation in gastric HM02 cells,
which are derived from a human well-differentiated mucus-
producing gastric carcinoma (Wagner et al, 1994), were grown for
3 days in RPMI-1640 medium supplemented with 10% fetal calf
serum (FCS) at 370C in a 5% carbon dioxide atmosphere. The cell
monolayers were then kept for 1 day in FCS-free medium and
trypsinated. Cell suspensions (1 x 106) were incubated with MOA at
37°C in 1 ml ofbuffermedium (pH7.4) forthe times indicated. The
buffer composition was (in mM): sodium chloride 70, sodium bicar-
bonate 20, sodium dihydrogen phosphate 0.5, disodium hydrogen
phosphate 1.0, Hepes 50, calcium chloride 1.0, magnesium chloride
1.5 and glucose 11 (buffer A). Afterwards, the cells were washed
once with calcium chloride-free buffer A andresuspended in 0.5 ml
ofice-cold 20 mm Tris (pH 7.4) and leupeptin at 20jg ml-' (buffer
B). All subsequent procedures were carried out at 4°C. The cells
were lysed by three 20-s bursts of sonication (power 30 W) and
centrifuged at 1 00000gfor30 min. The supematant was retained as
the cytosolic fraction, the pellet was rehomogenized in 0.5 ml
of buffer B containing 1 mm 3-[(3-cholamidopropyl)-dimethyl-
ammonio]-l-propane-sulphonate (CAPS) and stirred for 30 min.
To study translocation of PKC to different subcellular fractions,
107 HM02 cells were treated with 50 jM MOA for 30 min and
processed as described above. Subcellularfractions were obtainedby
differential centrifugation and defined by the distribution ofmarkers
as follows: 1500 g for 10min, nuclear pellet (PI); 15 000 g for
15 min, mitochondrial pellet (P2); 100 000g for 60 min, membrane
pellet (P3). The three pellets were rehomogenized in buffer B setting
theprotein concentration to 1 mg ml-' and PKC was solubilized with
1 mmCAPS. PKC activity wasdetermined inthepresence of0.3 mM
free calcium chloride and 50 jg ml-1 phosphatidylserine. Non-PKC
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Figure 2 Ca2+ dependency of protein kinase C activation by 5lM MOA (0),
10 igg ml-1 phosphatidylserine (PS) (O) (A) and 10 gg ml-' PS plus 5gM MOA
(0), 10 9g ml-' PS plus 1 igg ml-' 1,2-dioctanoyl-sn-glycerol (DIG8) (U)
(B). Free Ca2+ concentration was controlled by Ca2+ EGTA buffer. Results are
means ± s.e.m. of three independent experiments. *P< 0.05 vs the
calculated additive value obtained with PS and MOA alone; +P < 0.05 vs the
calculated additive value obtained with PS and DIG8 alone
activity, assayed in the absence ofcalcium chloride and ofphospho-
lipid was subtracted from the total values.
Marker assays and marker distribution in subcellular
fractions
DNA determination
DNA content was analysed by the diphenylamine reaction
(Richards, 1974) using calfthymus DNA as a standard.
Cytochrome c oxidase
Cytochrome c oxidase was used as a marker for mitochondria.
The enzyme activity was determined according to the method
described by Copperstein and Lazarow (1951).
Na+,K+-ATPase
Na+,K+-ATPase was used as a marker for plasma membranes.
Enzyme activity was assayed by the liberation of inorganic phos-
phate from ATP at 37°C in 1 ml of medium containing 20-50 jg
of protein, 20 mm Tris buffer, pH 7.4, 2 mm magnesium chloride,
2 mm Tris-ATP, 100 mm sodium chloride and 20 mm potassium
chloride in the absence and presence of0.1 mM ouabain.
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Figure 3 Effect of MOA on the reaction velocity of protein kinase C with
various concentrations of phosphatidylserine. Protein kinase C was assayed
with 200 gM free Ca2+ at various concentrations of phosphatidylserine in the
absence (0) or presence of 5 gM MOA (0). Results are means ± s.e.m. of
three independent experiments
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Figure 4 Effect of MOA on the intracellular distribution of protein kinase C
in HM02 cells. Cells were incubated with the fatty acid at the concentrations
indicated for 15 min at 370C and processed as described in Materials and
methods. Protein kinase C activity was determined in the soluble and
particulate fractions. Total protein kinase C activity (soluble plus particulate)
in untreated cells is set at 100%, to which all other values are related.
Results are means ± s.e.m. of three experiments. *P < 0.05 vs control
The assays were performed on P,-P3, the 100 000 g supematant
and the original cell homogenate. DNA was enriched inP,; 80 ± 4%
ofthe DNA present in the original cell homogenate was found in this
fraction, 15 ± 2.5% in P2. Cytochrome c oxidase was enriched in P2;
63 ± 12.6% ofthe total enzyme activity was present in P2, 30 ± 15%
in PI. Na+,K+-ATPase was enriched in P3 (58 ± 1% of total enzyme
activity), 34 ± 5% was detectable in P2 (values are means ± s.e.m. of
three experiments). DNA, cytochrome c oxidase and Na+,K+-ATPase
were not detectable in the 100 000g supernatant.
Protein determination
Protein was determined using the method ofLowry et al (1951).
Determination of DNA synthesis
HM02 cells were plated at2.5 x 104cells perwell into 24-well plates
and allowed to grow to confluence. Confluent cells were washed
twice with phosphate-buffered saline and incubated for 24 h in 1 ml
of serum-free RPMI-1640 medium. MOA (0.3-30gM) was added
to the cells. After4 h, 0.5 ,Ci [3H]thymidine was added and incuba-
tion continued for an additional 4 h. Incorporated radioactivity
Figure 5 Time course of MOA-induced intracellular redistribution of protein
kinase C activity in HM02 cells. Cells were incubated with 3 gm (0, *) or
30 gM (E, *) MOA. At the times indicated the cells were processed as
described in Materials and methods to yield the soluble (0, O) and
particulate (0, *) fractions in which protein kinase C activity was determined.
In each experiment, protein kinase C activity in the soluble and particulate
fraction at appropriate time control was set at 100%, to which all other values
are related. Results are means ± s.e.m. of three experiments. *P < 0.05 vs
appropriate control
was quantified by using an automated cell harvester, followed by
scintillation spectrometry.
Statistics
Results are expressed as means of three independent experiments.
For statistical analysis Student's t-test was used. P-values less than
0.05 were considered to be significant.
RESULTS
Activation of protein kinase C by MOA
The direct activation of PKC by MOA in the presence of 200 ,UM
free Ca2+ is shown in Figure 1. PKC was activated in the absence of
a phospholipid and a diglyceride by the fatty acid in a concentra-
tion-dependent manner. The Ka value was 3.3 jM. The maximal
reaction velocity with MOA (1922 ± 128 nmol 32p transferred
min-1 mg-' protein) was lower than that with saturating (50 jig ml-)
concentrations of phosphatidylserine (4480 ± 336 nmol 32p trans-
ferred min-1 mg-' protein). In the absence of Ca2+ (0.2 mm EGTA)
the fatty acid did not activate PKC.
The concentration dependence on Ca2+ of PKC activation in the
presence of 5 jiM MOA is shown in Figure 2A. Like the activation
by phosphatidylserine, the fatty acid activates PKC in a Ca2+-
dependent fashion. One characteristic of the phosphatidylserine
stimulation of PKC is that this can be augmented at low Ca2+
concentrations by diacylglycerols or phorbol esters (TPA). Figure
2B shows that MOA, like 1,2-dioctanoyl-sn-glycerol (DIC8),
greatly enhanced phosphatidylserine-induced activation of PKC at
low (1 jiM) Ca2+ concentrations. Although phosphatidylserine was
not required for MOA-supported PKC activation, the phospholipid
affected the reaction. In the presence of200 jiM free Ca2+the effects
of phosphatidylserine (1 and 5 jig ml-') were additive to those of
MOA. However, no additive effects were found at saturating (10
and 50 jg ml-') concentrations ofthe phospholipid (Figure 3).
Effect of MOA on intracellular distribution of protein
kinase C in gastric HM02 cells
Fractionation ofgastric HM02 cells yielded a soluble and a partic-
ulate fraction. Total PKC activity (soluble plus particulate) in
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Table 1 Effect of MOA (50gM) on the distribution of protein kinase C in
subcellular fractions of HM02 cells
PKC activity (pmol 32p mg-' protein min-')
Cell fraction -MOA +MOA
Nuclear(Pi) 58 ± 14 (5) 170 ± 24* (15)
Mitochondrial (P2) 213 ± 11 (19) 304 ± 33* (27)
Membranes (P3) 242 ± 14 (21) 355 ± 32* (32)
Cytosol 609 ± 43 (54) 294 ± 50* (26)
Total 1122 ± 23 1123 ± 123
HM02 cells were treated for 30 min with 50 ,uM MOA and the cell
homogenate was fractionated by differential centrifugation as described in
Material and methods. I is the total PKC activity obtained by summation of
the activity of each of the fractions. The percentage in each fraction of the
total activity is given in parenthesis. Values are means ± s.e.m. of three
experiments. *P< 0.05 vs control.
Table 2 Effect of MOA on [3H]thymidine incorporation into HM02 cell DNA
Treatment [3H]thymidine uptake (c.p.m.)
None 4376 ±390
MOA 0.3gM 4606 ±318
MOA 1 gM 6572 ± 373*
MOA 3gM 7595 + 187*
MOA 10gM 8108±400*
MOA 30gM 6855 ±253*
TGF-a (10 ng ml-') 8137+204*
Values are means ± s.e.m. of four determinations. *P< 0.05 vs control.
untreated cells was 1002 ± 87 pmol 32p transferred min-' mg-1
protein (n = three cell experiments). Approximately 50% of total
PKC activity was in the soluble fraction. The intracellular distrib-
ution of PKC after 15 min incubation with increasing concentra-
tions ofMOA is shown in Figure 4. MOA at concentrations of30,
50 and 100gM caused a decrease in soluble PKC activity that was
paralleled by an increase in enzyme activity in the particulate frac-
tion. The effect ofMOA on translocation ofPKC was time depen-
dent. Maximal decrease ofsoluble PKC activity was detectable 30
and 60 min afterthe addition ofMOA (3 and 30gM) to the cells. A
return to control levels was noted after 120 min ofincubation. The
activity of PKC in the particulate cell fraction behaved recipro-
cally (Figure 5).
Subcellular locations of translocated PKC
Table 1 shows the distribution of PKC activity in the subcellular
fractions of HM02 cells. PKC was found inPp, P2 and P3; signifi-
cant amounts were found in the mitochondrial (19%) and
membrane (21%) fraction. Treatment of HM02 cells with MOA
(50gM) resulted in a significant increase in PKC activity in all
particulate cell fractions. The enzyme activity increased threefold
inPi and 1.5-fold in the mitochondrial P2 and membrane pellet P3.
Effect of MOA on DNA synthesis
Table 2 demonstrates that MOA stimulates DNA synthesis of
HM02 cells. The threshold concentration was 1.0gM, maximal
response was seen at 10gM. The effect ofTGF-a (10 ng ml-') was
similar to that of 10gM MOA.
DISCUSSION
Our data demonstrate that the H.p. fatty acid MOA activates PKC,
both at the level of the isolated enzyme and at the level of the
intact cell and stimulates DNA synthesis.
Activation of PKC is a two-step process. The first step is the
formation of an enzyme-Ca2+-phospholipid (phosphatidylserine)
complex; the second step in association is the binding of diacyl-
glycerol (orphorbol esters), which through conformational changes
increases the affinity ofthe enzyme for Ca2+ and thereby renders it
fully active at submicromolar Ca2+ concentrations (Nishizuka,
1986). The characteristics of MOA-triggered PKC activation
provide evidence that this fatty acid interacts with two binding sites
ofthe enzyme: (a) MOA directly stimulates PKC in the absence of
phosphatidylserine; (b) at subsaturating concentrations phos-
phatidylserine enhances the effect ofMOA in a medium containing
200 gM Ca2+; and (c) MOA augments phosphatidylserine-stimu-
lated PKC activation at low (1 ,UM) Ca2+ concentrations. The results
(a) and (b) favour the hypothesis that MOA interacts with PKC in
the phospholipid-binding domain, whereas (c) indicates that MOA
in addition interacts with the diacylglycerol binding site of the
enzyme. Therefore, MOA can be regarded as a novel and unique
PKC activator. Other naturally occurring PKC activators, such as
retinoic acid (Ohkubo et al, 1984), bile acids (Huang et al, 1992),
lipid X (Wightman & Raetz, 1984) and unsaturated fatty acids such
as linoleic acid (Lester, 1990) have been found to interact with PKC
in the phospholipid-binding domain.
In gastric mucous cells that are likely targets for H.p., MOA
caused translocation ofPKC from the cytosol to the particular cell
fraction. In the nuclear cell fraction PKC activity was increased
threefold. Nuclear PKC has been shown to play an essential role in
the mitogenic effect ofplatelet-derived growth factor (Fields et al,
1990). In general, increased levels of nuclear PKC is associated
with cell proliferation (Clemens et al, 1992). However, PKC is a
family of enzymes consisting of at least nine isotypes. Thus,
certain signal transduction pathways may involve only single PKC
species. In particular, translocation and activation ofPKC-3 at the
nucleus has been suggested to play a role in growth regulation. In
Swiss 3T3 cells an overexpression of PKC-, (but not PKC-a)
enhanced growth rate (Eldar et al, 1990) and in K562
erythroleukaemia cells activation ofPKC-P,, by the PKC activator
bryostatin leads to a proliferative signal (Hocevar et al, 1992). The
PKC isotypes expressed in HM 02 cells and the specific isoform(s)
of PKC that mediates the action of MOA are not known. This
question will require additional investigation.
Several properties of H.p. may facilitate cancer development
without being specifically carcinogenic. H.p. gastritis is associated
with a significant decrease in the concentration ofascorbic acid in
gastricjuice (Banerjee et al, 1994).
Ascorbic acid is an antioxidant that has important functions as a
scavenger of reactive oxygen species and inhibits N-nitrosation
(Licht et al, 1988). A further response to H.p. infection is a
substantial increase in gastric epithelial cell turnover rates. Several
studies have shown an approximate doubling ofcell turnover rates
associated with H.p. and a restitution to normal levels after
successful eradication ofthe bacterium (Alam et al, 1994; Cahill et
al, 1994, 1995; Lynch et al, 1995). An increase in epithelial cell
proliferation is one ofthe earliest mucosal changes in the develop-
ment of gastric cancer (Deschner et al, 1972) and an increased
epithelial cell proliferation has been shown in macroscopically
normal tissue remote from gastric carcinoma (Brito et al, 1992).
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It has been suggested that ammonia, or ammonium-containing
substances, abundantly produced as a result ofH.p. urease activity,
may act as cancer promotors enhancing rates of cell division
(Tsujii et al, 1992). Recently, Fan and colleagues (1996) reported
that H.p. can directly stimulate proliferation of the gastric epithe-
lial cell line AGS. Our results demonstrate that the H.p. fatty acid
MOA activates PKC and initiates DNA synthesis in the mucous
cell line HM02. Therefore, we hypothesize that MOA may
account, at least in part, for the cell proliferative effect ofH.p. The
concentration ofMOA present in the H.p. infected gastric mucosa
is not known. We have found that approximately 30% (i.e. 630 ng
ofMOA from 108 H.p.) ofintracellular MOA are released from the
bacterium during 24-h log phase growth (C. Birkholz and W. Beil,
unpublished observations). This fatty acid amount would corre-
spond to approximately 2 gM MOA in a volume of 1 ml. At this
concentration MOA clearly stimulates PKC activity and enhances
DNA synthesis in mucous cells.
We conclude from this study that the H.p. fatty acid MOA acti-
vates PKC and increases DNA synthesis in the gastric epithelial
cell line HM02. We suggest that MOA-induced enhancement of
proliferative activity may render the gastric epithelial cells more
susceptible to carcinogenic stimuli and thereby contribute to the
enhanced risk ofgastric cancer in H.p. infected populations.
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